MedTrace Logo

Food Supplements Based on Nettle and Peppermint to Control Signs and Symptoms Induced by Cancer Therapies

NCT04474951 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-07-17

No results posted yet for this study

Summary

The main purpose of this study is to evaluate the impact of food supplements (herbal remedies) on sign and symptoms induced by cancer therapies: Nettle will be administered for improvement of anemia and fatigue; Peppermint will be administered for improvement of nausea. Secondary aims of the trial are to evaluate the impact of these supplements on the quality of life and to evaluate their tolerability profile.

Conditions

Interventions

DIETARY_SUPPLEMENT

Stinging Nettle

Eligible patients will take 40 drops TID of Fluid Extract of Stinging Nettle for control of anemia.

DIETARY_SUPPLEMENT

Stinging Nettle

Eligible patients will take 40 drops TID of Fluid Extract of Stinging Nettle for control of fatigue.

DIETARY_SUPPLEMENT

Peppermint

Eligible patients will take 40 drops TID of Fluid Extract of Peppermint for control of nausea.

Sponsors & Collaborators

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    lead OTHER

Principal Investigators

  • Claudio Zamagni, MD · Azienda Ospedaliero-Universitaria di Bologna, Policlinico S.Orsola-Malpighi SSD Oncologia Medica Addarii

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-20
Primary Completion
2021-03-01
Completion
2021-09-01

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04474951 on ClinicalTrials.gov